Case Report: Adaptive radiotherapy in the radiation salvage of prostate cancer

Steven K. Montalvo, Boyu Meng, Mu Han Lin, Chunjoo Park, Neil B. Desai, Raquibul Hannan, Aurelie Garant

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Adaptive radiotherapy has the potential to reduce margins, improve target coverage, and decrease toxicity to organs at risk (OARs) by optimizing radiation delivery to daily anatomic changes. Salvage for locally recurrent prostate cancer after definitive radiation remains a challenging clinical scenario given the risks to normal tissue in a setting of re-irradiation. Here, we present a case series of five patients with locally recurrent prostate cancer treated with an adaptive online linear accelerator or a 3-T MR-based linear accelerator to demonstrate excellent target coverage. All patients completed the planned treatment course with acceptable acute toxicities but a short follow-up time does not inform subacute/late toxicities.

Original languageEnglish (US)
Article number898822
JournalFrontiers in Oncology
StatePublished - Aug 15 2022


  • MR-guided
  • ablative
  • adaptive
  • prostate
  • radiation
  • salvage
  • stereotactic

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Case Report: Adaptive radiotherapy in the radiation salvage of prostate cancer'. Together they form a unique fingerprint.

Cite this